A fter acute hospitalization, many older patients in the United States are discharged to skilled nursing facilities (SNF). [1] [2] [3] [4] Medicare benefits cover up to 100 days of SNF care for patients hospitalized for at least 3 days who also have a skilled need. 5 This SNF care accounts for over $20 billion in Medicare costs annually. 6 Although heart failure (HF) is the leading cause of hospitalization and rehospitalization for Medicare patients, 7 variations in the use of SNF and clinical outcomes of patients discharged to SNF after HF hospitalization are relatively unknown. Consequently, efforts to learn more about the discharge status and related outcomes of patients after HF hospitalization are needed. 8 
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The Get With The Guidelines-Heart Failure (GWTG-HF) registry linked to Centers for Medicare and Medicaid Ser-vices (CMS) claims data provides an ideal cohort of hospitalized patients with HF to further examine discharge status and differences in care and outcomes of patients discharged to SNF. 9, 10 We set out to describe patient and hospital characteristics associated with discharge to SNF, assess hospital performance measures for patients discharged to SNF, and determine mortality and rehospitalization rates for HF patients discharged to SNF as compared with home.
Methods

Settings and Patients
Baseline patient data were obtained from the GWTG-HF Program, an ongoing observational, voluntary, continuous qualityimprovement initiative of the American Heart Association. 9 Participating institutions submit patient information on consecutive eligible patients admitted to the hospital with a primary diagnosis of HF regardless of left ventricular ejection fraction (LVEF). Trained personnel abstract the data using standardized definitions. Data collection includes demographics, clinical characteristics, use and contraindications for evidence-based therapies, in-hospital outcomes, and admission and discharge location. Clinical data use the point-of-service, interactive, Internet-based Patient Management Tool (Outcome Sciences, Inc, Cambridge, MA). The Internet-based system performs checks to ensure the completeness of the reported data. Additionally, data quality is monitored independently, and reports are generated to confirm the completeness and accuracy of submitted data. All participating institutions are required to comply with local regulatory and privacy guidelines and to submit the program protocols for review and approval by their institutional review boards. Because data are used primarily at the local site for quality improvement, sites are granted a waiver of informed consent under the common rule. Outcome Sciences, Inc, serves as the data collection and coordination center for GWTG-HF. The Duke Clinical Research Institute serves as the data analysis center.
GWTG-HF registry patients were linked with inpatient CMS claims files using indirect identifiers as previously published. 10 To be eligible for study inclusion, patients had to be discharged alive between January 1, 2005, and December 31, 2006, from a hospital fully participating in the GWTG-HF program, age 65 years or older, and enrolled in fee-for-service Medicare. Hospitals with Ͼ25% of GWTG-HF history panel forms incomplete and hospitals with Ͻ25 eligible study records were excluded. Under these criteria, 23 509 patients were initially eligible for the study. If there were multiple hospitalizations for the same patient during the eligibility period, we selected only the first. For the purposes of creating comparable groups for modeling outcomes by discharge to SNF versus home, we excluded patients discharged to a location other than SNF or home under self-care or home health (nϭ3207; including another shortterm hospital for inpatient care, nϭ403; intermediate care facility, nϭ611; rehabilitation facility, nϭ405; long-term care hospital, nϭ91; hospice at home, nϭ244; hospice at medical facility, nϭ197), patients with length of stay less than 3 days who would technically not meet CMS criteria for postacute SNF (nϭ4593), and patients admitted from a SNF (nϭ250). The final study population consisted of 15 459 unique older patients hospitalized at 149 sites.
Outcome Measures
The main outcome measures were all-cause mortality and all-cause rehospitalization at 30 days and 1 year from the time of discharge, chosen because of ongoing public reporting efforts targeting these measures. [11] [12] [13] 
Data Analyses
Continuous variables are presented as medians with differences between the 25th and 75th percentiles and categorical variables are presented as percentages. We compared baseline characteristics for patients discharged to SNF versus those discharged elsewhere using 2 tests for categorical variables and Wilcoxon rank sum tests for continuous variables. We also compared characteristics among hospitals divided by high, middle, and low tertiles for rates of SNF discharge. Event rates for mortality and rehospitalization were calculated using the Kaplan-Meier method.
Multivariable logistic regression modeling was used to assess in-hospital patient and institutional correlates of discharge to SNF. A generalized estimating equation method was used to adjust for clustering within hospitals. 14 The initial model included demographics (age, sex, race [white versus other]), medical history (chronic or recurrent atrial fibrillation, atrial flutter, cerebrovascular accident or transient ischemic attack, chronic obstructive pulmonary disease or asthma, diabetes, hyperlipidemia, hypertension, peripheral vascular disease, anemia, implantable cardioverter-defibrillator [ICD], pacemaker, chronic dialysis, renal insufficiency defined as serum creatinine chronically Ͼ2.0 mg/dL, depression, alcohol abuse, smoking), HF history (prior diagnosis of HF, ischemic etiology defined as prior myocardial infarction or coronary revascularization), clinical data at time of enrollment (systolic blood pressure, heart rate, blood urea nitrogen), and length of stay as determined from the from the case report form. Tests for linearity were assessed among continuous variables, and nonlinear variables were transformed into categorical variables based on commonly used cut-points in the literature. Additionally, interactions between age and sex were tested.
Missing data were Ͻ5% for all variables used in modeling, except for admission serum sodium (12.8%), serum creatinine (10.6%), hemoglobin (13.9%), heart rate (9.3%), and ejection fraction (7.8%). For the purposes of modeling predictors of discharge to SNF and for determining adjusted hazards ratios for the outcomes of interest, we excluded those patients with all laboratory data missing (nϭ860) and used conditional mean imputation for all remaining missing data.
A 2-tailed probability value of Ͻ0.05 was considered statistically significant for all tests. All analyses were performed using SAS software version 9.3 (SAS Institute, Cary, NC).
Results
Among 15 459 Medicare beneficiaries discharged alive to SNF or home after an index hospitalization for HF of 3 days or more at GWTG-HF hospitals who were not admitted from SNF, the median age was 80 years, just more than half were women, nearly half had ischemic heart disease, median LVEF was 45%, and median length of stay was 5 days ( Table 1 ).
Frequencies of Discharge Status
From the final cohort, 3727 (24.1%) study patients were discharged to an SNF. Among the original population considered for the study (before exclusions for shorter length of stay, admission location, or nonhome non-SNF discharge status), SNF accounted for 18.1% of discharges.
Patient Characteristics Associated With Discharge to an SNF
A wide variety of patient factors were associated with discharge to a SNF versus home ( Table 1 ). In multivariable analysis, patient characteristics associated with discharge to a SNF included longer length of stay, advanced age, a variety of comorbidities (history of depression, stroke, anemia, diabetes, peripheral vascular disease, chronic obstructive pulmonary disease or asthma), female sex, hypotension, uremia, higher ejection fraction, hypernatremia, and absence of hyperlipidemia, valvular heart disease, myocardial infarction, coronary revascularization, or ICD ( Table 2) . Addition of an age-by-sex interaction term was not significant in the model (Pϭ0.91).
Hospital Characteristics Associated With Rates of Discharge to SNF
At the hospital level, rates of discharge to SNF ranged widely (Table 3 ). There was significant regional variation in the use of SNF with use highest in the Northeast (30.0%) and lowest in the West (23.6%, PϽ0.0001, Table 1 ). Hospitals with the lowest rates of discharge to SNF were more likely to care for racial minorities and slightly younger patients (Table 3 ).
Discharge Quality Measures and Care Stratified by Discharge Status
To assess the extent to which SNF patients were treated differently than their counterparts, eligibility for and completion of HF performance measures at the time of hospital discharge were assessed according to discharge status. Patients discharged to SNF were slightly less likely to be eligible for angiotensin-converting enzyme inhibitor/angiotensin receptor blocker and ␤-blocker therapies at the time of hospital discharge, associated with the higher LVEF among patients discharged to SNF ( Table 1 ). The frequency of application of GWTG care performance measures in eligible patients was modestly less in patients discharged to SNF, with absolute differences in rates Ͻ10% (measures listed Table 1 ). Procedures during the index hospitalization were rare in all patients regardless of discharge status; ICD placement, cardioversion, percutaneous coronary intervention, coronary artery bypass graft surgery, and intra-aortic balloon pump placement all occurred at rates Ͻ1%.
Outcomes Stratified by Discharge Status
Patients discharged to an SNF had high rates of adverse events. Unadjusted postdischarge all-cause mortality was markedly higher for patients discharged to SNF compared with patients discharged elsewhere: 30-day mortality, 14.4% versus 4.1%, and 1-year mortality, 53.5% versus 29.1%, respectively; PϽ0.0001 (Figure, A) . All-cause rehospitalization rates were also higher in the patients discharged to SNF in comparison to their non-SNF counterparts: 30-day rehospitalization, 27.0% versus 23.5%, and 1-year rehospitalization, 76.1% versus 72.2%, respectively; PϽ0.0001 (Figure,  B) . For the combined end point of death or rehospitalization, rates were 35.2% versus 25.5% at 30 days and 83.6% versus 74.8% for SNF versus non-SNF discharge status, respectively; PϽ0.0001. Adjustment for in-hospital patient factors partially attenuated the association between discharge status and outcomes (Table 4 ).
Discussion
Using a large contemporary prospective observational database, we found that discharge to SNF occurs in approximately 1 in 5 Medicare beneficiaries after hospitalization for HF. The vast majority of patients discharged to a SNF were previously residing at home. Discharge to SNF is associated with patient factors, region of care, and modestly lower performance on existing inpatient quality measures. The subsequent risk for mortality is substantial, with more than half of these patients dead at 1 year. Compared with similar patients discharged to home, discharge to SNF is associated with a 76% increased risk of death after adjustment for a wide-range of patient characteristics known to be associated with adverse outcomes. However, discharge to SNF is by its very nature determined by criteria such as poor mobility, cognitive impairment, frailty, and poor in-home support, which are also important determinants of outcome but are not directly captured in the analyses provided here. Irrespective of the underlying causes of this disproportionate rate of mortality, there are potential implications in terms of prognostic communication, medical decision-making, and targeted assessment of care provided at SNFs. Given the financial and policy implications, the relative paucity of evidence regarding the use of postacute SNF care in patients with hospitalization for HF represents an important gap in knowledge. Based on available National Health Expenditure data, the CMS Prospective Payment System spent $19.1 billion on SNF care in 2005 and is expected to spend $29.3 billion in 2011. 6 As the leading cause of hospitalization and rehospitalization for Medicare patients, 7 the care for patients with HF accounts for a significant portion of these costs. A number of high-profile publications have begun to address the utilization and subsequent outcomes of various discharge dispositions. For Medicare hospitalizations involving admission to an intensive care unit, 2 studies have looked at outcomes stratified by discharge location, including skilled care facilities and long-term acute care facilities. 15, 16 Trends in length of stay and short-term outcomes among Medicare fee-for-service beneficiaries hospitalized with HF were recently published, including the finding that rates of discharge to "SNF or intermediate care facility" rose from 13.2% to 19.6% between 1993 and 2006 at the same time that length of stay has been shortened and 30-day rehospitalizations have increased. 17 Among the general SNF population, high 30-day rates of rehospitalization have also recently been recognized. 18 Our results complement these purely administrative data analyses by providing prospective collection of clinical data to better characterize those patients discharged to SNF and inform adjusted analysis associating discharge status with outcome. To our knowledge, the findings presented here are the first to systematically characterize subsequent outcomes for patients discharged to SNF and non-SNF locations after acute hospitalization for HF. The high absolute rates of death after discharge to SNF for patients hospitalized with HF have potential implications for communication, discharge planning, and goals of care. The Institute of Medicine 19 and national HF guidelines recom-mend that patients and their families be "provided with prognostic information to help appropriately plan for their futures." 20 We postulate that the overall process of transitioning a patient with HF from home to hospital to SNF is likely to require significant discussions and planning between the patient, family, and care providers. Thus, this peridischarge period may also represent an opportune time to consider: (1) transmission of tailored information regarding ranges of expectations for survival and rehospitalization in this high risk group of patients; (2) deliberation of alternatives to SNF for certain patients, including hospice; and (3) formal consideration of overall goals of care including code status and plans regarding potential rehospitalization for worsening health status. Data suggest that patients who have prepared advance directives receive care that is better associated with their preferences. 21 Formalized processes for assessing and recording patient and family wishes regarding certain therapies including rehospitalization may be particularly useful in the management of patients with HF transitioned to a SNF. 22 Further studies that provide longitudinal data regarding the range of patient experiences after discharge to SNF would further help to guide these types of discussions. Although unmeasured confounding almost certainly accounts for at least some of the residual association between discharge status and increased mortality, the persistent increases in mortality after restriction of the cohort and subse-quent adjustment for measured covariates raises the possibility that differences in care provided at SNF versus other discharge locations after HF hospitalization may play a role in these adverse outcomes. We saw some differences in the use of discharge quality of-care measures when stratified by discharge status, but the absolute differences in these quality measures for eligible patients were smaller than the absolute difference in adjusted mortality. However, the data analyzed in the present study only characterize care quality up to the time of discharge and provide no insight into the processes of care provided at SNFs. Although no cause-and-effect relationship can or should be drawn from these observational results, the differences seen here emphasize the need for future studies that evaluate postdischarge care of patients with HF, with particular focus of SNF care. Published data on long-term care hospitals suggest that serious violations of Medicare rules are approximately double those of regular hospitals, 23 whereas systematic assessment of SNF care is currently lacking.
The GWTG-HF registry participation is largely motivated by a desire to improve key performance measures related to processes of care. Until now, there has been no basis for different processes of care for patients discharged to SNF versus those discharged to home. Even for the frailest of patients without obvious contraindications, application of the performance measures among eligible patients may have the benefit of improving symptoms and quality of life. Despite this, most existing analyses of discharge performance for HF quality measures have excluded patients discharged to SNF. Patients discharged to SNF represent a significant fraction of the more than 1 million HF hospitalizations each year 1 and thus should not be merely ignored. In addition to considering how well the existing quality measures apply to patients discharged to SNF, we must consider other processes of care that may be distinctly relevant to this unique population, potentially focusing on frailty, symptom relief, and end-oflife issues for those at the highest risk. Certain factors and limitations should be considered in the interpretation of the results of this study. Participation in the GWTG-HF registry is voluntary and thus may select for hospitals with certain characteristics, thereby resulting in selection bias. However, patient characteristics and outcomes for hospitals in the precursor program to GWTG-HF were similar to the nation as a whole for fee for service Medicare patients. 24 In merging GWTG data with CMS data to obtain longitudinal follow-up, the patient population was restricted to only those patients age 65 years or older. However, 80% of patients hospitalized with HF are age 65 or older, 1 and approximately 80% of those are covered by the Medicare fee-for-service program, 25 making the findings and conclusions of this study applicable to the majority of HF patients. The data on discharge status are reported by personnel who may not be entirely familiar with the formal differences between various types of discharge destinations, although clear definitions were provided during training and in the operating manual to supplement the case report form and the fields for capturing discharge status were designed to parallel CMS discharge codes. Comparison of discharge codes entered into GWTG-HF with those from the MEDPAR database demonstrated 94% agreement. We cannot exclude the possibility that SNF was being used in a hospice capacity for some patients, although the low rate of "comfort measures only" status among patients discharged to SNF (3.6%) compared with comfort measures only status among those discharged to hospice (25.7%) suggests that this is likely to be a rare occurrence. Missing data were minimal for most variables; in particular, discharge status was missing on only 0.2% of patients initially considered for this analysis. From the data, we cannot conclude whether discharge to SNF has any direct impact on patient outcomes or whether these differences in outcomes are related to unmeasured patient characteristics which also drive discharge disposition decisions. We had only limited data on the living situation of patients after their discharge to SNF, thus limiting the ability to characterize the average length of stay in SNF, the frequency with which patients were transitioned to long-term care, or the rate at which patients were able to leave a SNF and return to home. Finally, as a result of the large sample size, some small differences in absolute terms are still highly statistically significant.
Conclusions
Discharge to SNF occurs in approximately than 1 in 5 patients admitted to the hospital for HF. Patients discharged to SNF face a very high risk for death or rehospitalization. These results highlight the need to evaluate care processes and outcomes in the SNF setting. Additionally, we must consider whether a different set of quality measures are needed for this unique group of patients. 
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